Hospira Dacarbazine for Injection BP, 200 mg vial

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

dacarbazine, Quantity: 200 mg

Доступна с:

Hospira Australia Pty Ltd

ИНН (Международная Имя):

Dacarbazine

Фармацевтическая форма:

Injection, powder for

состав:

Excipient Ingredients: citric acid monohydrate; mannitol; sodium hydroxide

Администрация маршрут:

Intravenous

Штук в упаковке:

1 x 20 mL vial

класс:

Medicine Listed (Export Only)

Тип рецепта:

Not scheduled. Not considered by committee

Терапевтические показания :

Dacarbazine is indicated for the treatment of patients with metastatic malignant melanoma. Dacarbazine is used as part of combination chemotherapy for the treatment of advanced Hodgkin's disease, advanced adult soft tissue sarcomas (except mesothelioma and Kaposi sarcoma). Dacarbazine has been shown, when used in combination with other cytotoxic agents, to be of use in the treatment of other malignant diseases including carcinoma of the colon, ovary, breast, lung, testicular teratoma, and solid tumours in children.

Обзор продуктов:

Visual Identification: A white or very pale yellow powder or plug; Container Type: Vial; Container Life Time: 18 Months

Статус Авторизация:

Licence status A

Дата Авторизация:

2006-02-15